First Republic Investment Management, Inc. Exelixis, Inc. Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
A detailed history of First Republic Investment Management, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 13,491 shares of EXEL stock, worth $350,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,491
Previous 13,743
1.83%
Holding current value
$350,226
Previous $262,000
12.21%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$870 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$770 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$704 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$394 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$327 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.35B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...